FOXO4-DRI is a synthetic peptide studied in senescence research, where it is examined for its interactions with p53 pathways and its potential influence on cellular ageing processes. Research models frequently assess its role in apoptosis, longevity pathways, and age-related cellular mechanisms.
Each pack contains sterile, lyophilised FOXO4-DRI vials optimised for stability and controlled laboratory analysis. This compound is intended exclusively for scientific research and is not approved for therapeutic use.
